Hendri Susilo, - and Budi Susetyo Pikir, - and Mochammad Thaha, - and Mochamad Yusuf Alsagaff, - and Satriyo Dwi Suryantoro, - and Citrawati Dyah Kencono Wungu, - and Ifan Ali Wafa, - and Cennikon Pakpahan, - and Delvac Oceandy, - (2022) The Effect of Angiotensin Converting Enzyme (ACE) I/D Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in Non-Hemodialyzed Chronic Kidney Disease: The Mediating Role of Plasma ACE Level. Genes, 13 (7). ISSN 2073-4425

	Text (Artikel) 13. The Effect of Angiotensin Converting Enzyme (ACE) ID Polymorphism on Atherosclerotic Cardiovascular Disease and Cardiovascular Mortality Risk in NonHemodialyzed ChronicKidney.pdf Download (3MB)
	Text (Peer Review) karil 13.pdf Download (97kB)
	Text (Similariti) 13. Turnitin.pdf Download (4MB)

Abstract

The association between angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphisms and plasma ACE levels may allow for the optimization of a preventive intervention to reduce cardiovascular morbidity and mortality in the chronic kidney disease (CKD) population. In this study, we aimed to analyze the association between ACE I/D polymorphism and cardiovascular mortality risk among non-hemodialyzed chronic kidney disease patients. This cross-sectional study examined 70 patients of Javanese ethnic origin with stable CKD who did not receive hemodialysis. ACE I/D polymorphisms, plasma ACE levels, atherosclerotic cardiovascular disease (ASCVD) risk, and cardiovascular mortality risk were investigated. As per our findings, the I allele was found to be more frequent (78.6) than the D allele (21.4), and the DD genotype was less frequent than the II genotype (4.3 vs. 61.4). The ACE I/D polymorphism had a significant direct positive effect on plasma ACE levels (path coefficient = 0.302, p = 0.021). Similarly, plasma ACE levels had a direct and significant positive effect on the risk of atherosclerotic cardiovascular disease (path coefficient = 0.410, p = 0.000). Moreover, atherosclerotic cardiovascular disease risk had a significant positive effect on cardiovascular mortality risk (path coefficient = 0.918, p = 0.000). The ACE I/D polymorphism had no direct effect on ASCVD and cardiovascular mortality risk. However, our findings show that the indirect effects of high plasma ACE levels may be a factor in the increased risk of ASCVD and cardiovascular mortality in Javanese CKD patients.

Actions (login required)

View Item